To confirm the MM.1S-CBR-GFP-WT human MM cell line as a CD38 positive MM mouse model for CD38-targeted therapies, internal GFP reporter expression within MM.1S-CBR-GFP-WT human MM cell line was demonstrated via immunocytochemistry and immunohistochemistry. The gene discussed is CD38; the disease is Miyoshi myopathy.